Home / Oil and Gas / Keratoconus Global Clinical Trials Review, H2, 2015

Keratoconus Global Clinical Trials Review, H2, 2015

Published: Jul 2015 | No Of Pages: 72 | Published By: GlobalData

Keratoconus Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Keratoconus Global Clinical Trials Review, H2, 2015" provides an overview of Keratoconus clinical trials scenario. This report provides top line data relating to the clinical trials on Keratoconus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Keratoconus 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Keratoconus to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Keratoconus to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Keratoconus 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Keratoconus Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Avedro, Inc. 31
Clinical Trial Overview of Avedro, Inc. 31
Topcon Corporation 32
Clinical Trial Overview of Topcon Corporation 32
Peschke Meditrade GmbH 33
Clinical Trial Overview of Peschke Meditrade GmbH 33
Vasan Healthcare Private Limited 34
Clinical Trial Overview of Vasan Healthcare Private Limited 34
Rush Eye Associates 35
Clinical Trial Overview of Rush Eye Associates 35
Price Vision Group 36
Clinical Trial Overview of Price Vision Group 36
Narayana Nethralaya 37
Clinical Trial Overview of Narayana Nethralaya 37
Cxlusa 38
Clinical Trial Overview of Cxlusa 38
Crowd Health Research, Ltd 39
Clinical Trial Overview of Crowd Health Research, Ltd 39
Clinical Trial Overview of Top Institutes / Government 40
Federal University of Sao Paulo 40
Clinical Trial Overview of Federal University of Sao Paulo 40
The Cornea and Laser Eye Institute 41
Clinical Trial Overview of The Cornea and Laser Eye Institute 41
Democritus University of Thrace 42
Clinical Trial Overview of Democritus University of Thrace 42
Isfahan University of Medical Sciences 43
Clinical Trial Overview of Isfahan University of Medical Sciences 43
Al-Noor Eye Hospital 44
Clinical Trial Overview of Al-Noor Eye Hospital 44
Azienda Ospedaliera - Universitaria di Modena 45
Clinical Trial Overview of Azienda Ospedaliera - Universitaria di Modena 45
Azienda Ospedaliera Universitaria Senese 46
Clinical Trial Overview of Azienda Ospedaliera Universitaria Senese 46
Department of Health, South Africa 47
Clinical Trial Overview of Department of Health, South Africa 47
Emory University 48
Clinical Trial Overview of Emory University 48
HaEmek Medical Center 49
Clinical Trial Overview of HaEmek Medical Center 49
Five Key Clinical Profiles 50
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 72

List of Tables
Keratoconus Therapeutics, Global, Clinical Trials by Region, 2015* 7
Keratoconus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Keratoconus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Keratoconus Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Keratoconus Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Keratoconus Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Keratoconus Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Keratoconus Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Keratoconus to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Keratoconus Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Keratoconus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Keratoconus to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Keratoconus Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Keratoconus Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Keratoconus Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Keratoconus Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Keratoconus Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Keratoconus Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24
Keratoconus Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Keratoconus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Keratoconus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Keratoconus Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Keratoconus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Keratoconus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by Avedro, Inc., 2015* 31
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by Topcon Corporation, 2015* 32
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by Peschke Meditrade GmbH, 2015* 33
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by Vasan Healthcare Private Limited, 2015* 34
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush Eye Associates, 2015* 35
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by Price Vision Group, 2015* 36
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by Narayana Nethralaya, 2015* 37
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by Cxlusa, 2015* 38
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by Crowd Health Research, Ltd, 2015* 39
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015* 40
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cornea and Laser Eye Institute, 2015* 41
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by Democritus University of Thrace, 2015* 42
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 43
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by Al-Noor Eye Hospital, 2015* 44
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera - Universitaria di Modena, 2015* 45
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria Senese, 2015* 46
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2015* 47
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2015* 48
Keratoconus Therapeutics Clinical Trials Market, Global, Clinical Trials by HaEmek Medical Center, 2015* 49

List of Figures
Keratoconus Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Keratoconus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Keratoconus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Keratoconus Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Keratoconus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Keratoconus Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Keratoconus to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Keratoconus Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Keratoconus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Keratoconus to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Keratoconus Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Keratoconus Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Keratoconus Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Keratoconus Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Keratoconus Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Keratoconus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Keratoconus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Keratoconus Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Keratoconus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Keratoconus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 70

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +